Title : An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction.

Pub. Date : 2018 Jun

PMID : 29777521






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Most patients initiated sacubitril/valsartan at the lowest dose of 24/26 mg twice a day (BID), which remained unchanged during the observation period for half of the patients. Valsartan BH3 interacting domain death agonist Homo sapiens